Author

Elsa Campôa

Observed names: E. Campoa, E. Campôa, Elsa Campoa, Elsa Filipa Campoa, Elsa Reis Campoa

Institution: Unidade Local de Saúde do Algarve

Observed institutions: Hospital de Faro EPE, Centro de Investigação em Biociências e Tecnologias da Saúde, Unidade Local de Saúde do Algarve, Universidade Lusófona

ORCID: 0000-0003-3954-5238

Observed ORCID: 0000-0003-3954-5238

OpenAlex ID: A5005217942

Autonomy and dyspnea in palliative care: A case report

2019 · M. Martins, E. Campôa, et al. · Pulmonology · 9

PDF

Factors That Influence the Prescription of Antibiotic Therapy at the End-of-Life: Construction and Validation of a Scale

2022 · Elsa Campoa, Paulo Reis-Pina · Cureus · 4

PDF

Calidad de vida relacionada con la salud en pacientes con déficit de α1 antitripsina: estudio transversal

2016 · Margarida Torres Redondo, Elsa Campoa, et al. · Archivos de Bronconeumología · 4

End-of-Life Antibiotherapy: Factors Associated With Prescription

2022 · Elsa Campoa, Júlio Teixeira, et al. · Cureus · 3

PDF

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study

2026 · Diogo Martins-Branco, Soraia Lobo-Martins, et al. · Breast Cancer Research and Treatment · 2

Exploring the feasibility and implications of cranioencephalic computed tomography in HER2-positive breast cancer: A pilot study

2024 · Ana Fortuna, Paulo Luz, et al. · Heliyon · 2

Geriatric screening and comprehensive geriatric assessment during initial oncology appointments

2024 · Tânia Madureira, Joana Magalhães, et al. · BMJ Supportive & Palliative Care · 2

Value of rebiopsy in advanced Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer: Real-world data

2020 · R. Saúde-Conde, S. Cristóvão-Ferreira, et al. · Pulmonology · 2

PDF

2026 · Gonçalo Fernandes, Isabel Augusto, et al. · Journal of Clinical Oncology · 1

Systemic treatment of HER2-positive breast cancer patients with brain metastases: current status and exploratory case study in a Portuguese cohort

2021 · Paulo Luz, Elsa Campoa, et al. · Biomedical and Biopharmaceutical Research · 1

PDF

The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort

2021 · P. Luz, I. Fernandes, et al. · The Breast · 1

PDF

Assessment methods of pathological complete response in neoadjuvant head and neck cancer clinical trials: a scoping review

2026 · Peter Robinson, Charlotte Catrina Currie, et al. · The Journal of Pathology Clinical Research

PDF

OncoSEGUE: Transforming cancer care delivery through a decentralized, community-integrated oncology model in Southern Portugal.

2026 · Ana Varges Gomes, Elsa Filipa Campoa, et al. · Journal of Clinical Oncology

PDF

International variation in diagnostic and treatment practices in patients with HER2+ EBC: The RWE PEARL-HER2 study.

2026 · Soraia Lobo-Martins, Sergio Rivero, et al. · Journal of Clinical Oncology

Abstract PS3-11-23: Cross-country Treatment Practices after pCR Following Neoadjuvant Trastuzumab (H) and Pertuzumab (P) in HER2+ Early Breast Cancer: Preliminary Results from the PEARL-HER2 Study

2026 · S. Lobo-Martins, G. Gentile, et al. · Clinical Cancer Research

Post neoadjuvant HER2 treatment: real world data from a multicentric cohort

2021 · P. Luz, I. Fernandes, et al. · The Breast

PDF

1355P Value of rebiopsy in advanced epidermal growth factor receptor mutated non-small cell lung cancer: Real-world data

2020 · R.S. Conde, S.C. Ferreira, et al. · Annals of Oncology

PDF

Treating Bones in Metastatic Breast Cancer

2019 · Elsa Campôa, Tânia Madureira, et al. · The Breast

Advanced Breast Cancer in Young Women: Outcome of a Portuguese Hospital

2017 · David da Silva Dias, Elsa Campoa, et al. · The Breast

2016 · Margarida Torres Redondo, Elsa Campoa, et al. · Archivos de Bronconeumología

PDF

2015 · Margarida Torres Redondo, Elsa Campoa, et al. · European Respiratory Journal

Works count: 21

Citation count: 31

H-index: 3

I10-index: